(Reuters) -GE HealthCare Technologies cut its full-year profit forecast on Wednesday, as the medical device maker faces hits on multiple fronts due to an escalating global trade war.
U.S. President Donald Trump has been particularly focused on China, ratcheting up tariffs to eye-watering levels on a key source of raw materials for the pharmaceutical and medical device sectors.
His administration has also launched an investigation into imports of pharmaceuticals and semiconductors in a bid to impose tariffs on both sectors.
The company expects an 85 cent impact to its adjusted 2025 per share profit, with the range now at $3.90 to $4.10 per share, compared with its previous forecast of between $4.61 and $4.75 per share.
GE HealthCare said that the tariff impact forecast includes assumptions on bilateral tariffs between the U.S. and China, tariffs on Mexico and Canada, as well as reciprocal tariffs that the Trump administration has placed on the rest of the world.
(Reporting by Puyaan Singh in Bengaluru; Editing by Pooja Desai)
Comments